{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:38:17Z","timestamp":1780569497364,"version":"3.54.1"},"reference-count":119,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>More than a decade after the discovery of p16 immunohistochemistry (IHC) as a surrogate for human papilloma virus (HPV)-driven head and neck squamous cell carcinoma (HNSCC), p16-IHC has become a routinely evaluated biomarker to stratify oropharyngeal squamous cell carcinoma (OPSCC) into a molecularly distinct subtype with favorable clinical prognosis. Clinical trials of treatment de-escalation frequently use combinations of biomarkers (p16-IHC, HPV-RNA <jats:italic>in situ<\/jats:italic> hybridization, and amplification of HPV-DNA by PCR) to further improve molecular stratification. Implementation of these methods into clinical routine may be limited in the case of RNA by the low RNA quality of formalin-fixed paraffin-embedded tissue blocks (FFPE) or in the case of DNA by cross contamination with HPV-DNA and false PCR amplification errors. Advanced technological developments such as investigation of tumor mutational landscape (NGS), liquid-biopsies (LBx and cell-free cfDNA), and other blood-based HPV immunity surrogates (antibodies in serum) may provide novel venues to further improve diagnostic uncertainties. Moreover, the value of HPV\/p16-IHC outside the oropharynx in HNSCC patients needs to be clarified. With regards to therapy, postoperative (adjuvant) or definitive (primary) radiochemotherapy constitutes cornerstones for curative treatment of HNSCC. Side effects of chemotherapy such as bone-marrow suppression could lead to radiotherapy interruption and may compromise the therapy outcome. Therefore, reduction of chemotherapy or its replacement with targeted anticancer agents holds the promise to further optimize the toxicity profile of systemic treatment. Modern radiotherapy gradually adapts the dose. Higher doses are administered to the visible tumor bulk and positive lymph nodes, while a lower dose is prescribed to locoregional volumes empirically suspected to be invaded by tumor cells. Further attempts for radiotherapy de-escalation may improve acute toxicities, for example, the rates for dysphagia and feeding tube requirement, or ameliorate late toxicities like tissue scars (fibrosis) or dry mouth. The main objective of current de-intensification trials is therefore to reduce acute and\/or late treatment-associated toxicity while preserving the favorable clinical outcomes. Deep molecular characterization of HPV-driven HNSCC and radiotherapy interactions with the tumor immune microenvironment may be instructive for the development of next-generation de-escalation strategies.<\/jats:p>","DOI":"10.3389\/fphar.2021.753387","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T05:48:36Z","timestamp":1642657716000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Evolution of a Paradigm Switch in Diagnosis and Treatment of HPV-Driven Head and Neck Cancer\u2014Striking the Balance Between Toxicity and Cure"],"prefix":"10.3389","volume":"12","author":[{"given":"Bouchra","family":"Tawk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients with Unresectable Squamous Cell Head and Neck Cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ijc.29683","article-title":"CD8+ Tumour-Infiltrating Lymphocytes in Relation to HPV Status and Clinical Outcome in Patients with Head and Neck Cancer after Postoperative Chemoradiotherapy: A Multicentre Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)","volume":"138","author":"Balermpas","year":"2016","journal-title":"Int. J. Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1016\/j.ijrobp.2019.06.295","article-title":"PIK3CA Mutation Is an Adverse Prognostic Factor in HPV-Associated Oropharynx Cancer","volume":"105","author":"Beaty","year":"2019","journal-title":"J Natl Cancer Inst."},{"key":"B5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djz224","article-title":"PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation","volume":"112","author":"Beaty","year":"2019","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1200\/JCO.2007.13.3983","article-title":"Evaluation of Early and Late Toxicities in Chemoradiation Trials","volume":"25","author":"Bentzen","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/hed.20279","article-title":"Defining Risk Levels in Locally Advanced Head and Neck Cancers: A Comparative Analysis of Concurrent Postoperative Radiation Plus Chemotherapy Trials of the EORTC (#22931) and RTOG (# 9501)","volume":"27","author":"Bernier","year":"2005","journal-title":"Head Neck"},{"key":"B8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ijrobp.2007.03.010","article-title":"Effects of Prolongation of Overall Treatment Time Due to Unplanned Interruptions during Radiotherapy of Different Tumor Sites and Practical Methods for Compensation","volume":"68","author":"Bese","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy Plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S1283","DOI":"10.1016\/annonc\/annonc741","article-title":"Avelumab-cetuximab-radiotherapy versus Standards of Care in Patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LA-SCCHN): Ran. OncologyPRO","volume":"32","author":"Bourhis","year":"2021","journal-title":"Ann. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/J.RADONC.2013.06.035","article-title":"HPV-positive HNSCC Cell Lines but Not Primary Human Fibroblasts Are Radiosensitized by the Inhibition of Chk1","volume":"108","author":"Busch","year":"2013","journal-title":"Radiother. Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1470-2045(17)30246-2","article-title":"Reduced-dose Radiotherapy for Human Papillomavirus-Associated Squamous-Cell Carcinoma of the Oropharynx: a Single-Arm, Phase 2 Study","volume":"18","author":"Chen","year":"2017","journal-title":"Lancet Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1200\/JCO.19.01007","article-title":"Phase II Trial of De-intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma","volume":"37","author":"Chera","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1200\/JCO.19.02444","article-title":"Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer","volume":"38","author":"Chera","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1200\/JCO.2017.35.15_suppl.6044","article-title":"Two-year Clinical Outcomes of De-intensified Chemoradiotherapy for Low-Risk HPV-Associated Oropharyngeal Squamous Cell Carcinoma","volume":"35","author":"Chera","year":"2017","journal-title":"Jco"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e123837","DOI":"10.1172\/JCI.INSIGHT.123837","article-title":"Carbon Irradiation Overcomes Glioma Radioresistance by Eradicating Stem Cells and Forming an Antiangiogenic and Immunopermissive Niche","volume":"4","author":"Chiblak","year":"2019","journal-title":"JCI Insight"},{"key":"B17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/J.RADONC.2015.07.042","article-title":"Patterns of Long-Term Swallowing Dysfunction after Definitive Radiotherapy or Chemoradiation","volume":"117","author":"Christianen","year":"2015","journal-title":"Radiother. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1200\/JCO.2007.10.8951","article-title":"Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology Group Study E2399","volume":"25","author":"Cmelak","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41416-019-0414-9","article-title":"Recommendations for Determining HPV Status in Patients with Oropharyngeal Cancers under TNM8 Guidelines: a Two-Tier Approach","volume":"120","author":"Craig","year":"2019","journal-title":"Br. J. Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1158\/1078-0432.CCR-14-3323","article-title":"HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx","volume":"21","author":"Dahlstrom","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1200\/JCO.2015.64.6448","article-title":"Proposed Staging System for Patients with HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories","volume":"34","author":"Dahlstrom","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1758-3284-2-15","article-title":"Meta-analysis of the Impact of Human Papillomavirus (HPV) on Cancer Risk and Overall Survival in Head and Neck Squamous Cell Carcinomas (HNSCC)","volume":"2","author":"Dayyani","year":"2010","journal-title":"Head Neck Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1158\/0008-5472.CAN-13-2479","article-title":"p16INK4a Impairs Homologous Recombination-Mediated DNA Repair in Human Papillomavirus-Positive Head and Neck Tumors","volume":"74","author":"Dok","year":"2014","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human Papillomavirus Molecular Biology and Disease Association","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/J.IJROBP.2010.12.067","article-title":"Chemo-IMRT of Oropharyngeal Cancer Aiming to Reduce Dysphagia: Swallowing Organs Late Complication Probabilities and Dosimetric Correlates","volume":"81","author":"Eisbruch","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.ijrobp.2004.05.050","article-title":"Dysphagia and Aspiration after Chemoradiotherapy for Head-And-Neck Cancer: Which Anatomic Structures Are Affected and Can They Be Spared by IMRT","volume":"60","author":"Eisbruch","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1200\/JCO.2006.06.1291","article-title":"Clinical Implications of Human Papillomavirus in Head and Neck Cancers","volume":"24","author":"Fakhry","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved Survival of Patients with Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1200\/JCO.2014.55.1937","article-title":"Human Papillomavirus and Overall Survival after Progression of Oropharyngeal Squamous Cell Carcinoma","volume":"32","author":"Fakhry","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/jamaoncol.2019.0439","article-title":"Association of Oral Human Papillomavirus DNA Persistence with Cancer Progression after Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma","volume":"5","author":"Fakhry","year":"2019","journal-title":"JAMA Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1200\/JCO.2009.24.6199","article-title":"Intensity-modulated Chemoradiotherapy Aiming to Reduce Dysphagia in Patients with Oropharyngeal Cancer: Clinical and Functional Results","volume":"28","author":"Feng","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"JCO2101752","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable P16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)","author":"Ferris","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1200\/jco.2020.38.15_suppl.6500","article-title":"Transoral Robotic Surgical Resection Followed by Randomization to Low- or Standard-Dose IMRT in Resectable P16+ Locally Advanced Oropharynx Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E3311)","volume":"38","author":"Ferris","year":"2020","journal-title":"Jco"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/J.IJROBP.2008.04.006","article-title":"Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)","volume":"71","author":"Garden","year":"2008","journal-title":"Int. J. Radiat. Biol. Phys."},{"key":"B35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy Plus Cetuximab or Cisplatin in Human Papillomavirus-Positive Oropharyngeal Cancer (NRG Oncology RTOG 1016): a Randomised, Multicentre, Non-inferiority Trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1200\/JCO.2011.38.4099","article-title":"Tobacco Smoking and Increased Risk of Death and Progression for Patients with P16-Positive and P16-Negative Oropharyngeal Cancer","volume":"30","author":"Gillison","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"v184","DOI":"10.1093\/annonc\/mdq185","article-title":"Squamous Cell Carcinoma of the Head and Neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","author":"Gr\u00e9goire","year":"2010","journal-title":"Ann. Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijrobp.2016.02.021","article-title":"Clinical Outcomes and Patterns of Disease Recurrence after Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma","volume":"95","author":"Gunn","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e12279","DOI":"10.1172\/JCI.INSIGHT.122799","article-title":"Improved Outcomes in PI3K-Pathway-Altered Metastatic HPV Oropharyngeal Cancer","volume":"3","author":"Hanna","year":"2018","journal-title":"JCI Insight"},{"key":"B40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.oraloncology.2017.02.022","article-title":"Complications Following Transoral Robotic Surgery (TORS): A Detailed Institutional Review of Complications","volume":"67","author":"Hay","year":"2017","journal-title":"Oral Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/jnci\/djg107","article-title":"Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study","volume":"95","author":"Herrero","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"B42","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/J.IJROBP.2010.08.031","article-title":"Atypical Clinical Behavior of P16-Confirmed HPV-Related Oropharyngeal Squamous Cell Carcinoma Treated with Radical Radiotherapy","volume":"82","author":"Huang","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.oraloncology.2012.07.015","article-title":"Natural Course of Distant Metastases Following Radiotherapy or Chemoradiotherapy in HPV-Related Oropharyngeal Cancer","volume":"49","author":"Huang","year":"2013","journal-title":"Oral Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1200\/JCO.2014.58.6412","article-title":"Refining American Joint Committee on Cancer\/Union for International Cancer Control TNM Stage and Prognostic Groups for Human Papillomavirus-Related Oropharyngeal Carcinomas","volume":"33","author":"Huang","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/jamaoto.2019.2725","article-title":"Dysphagia after Primary Transoral Robotic Surgery with Neck Dissection vs Nonsurgical Therapy in Patients with Low- to Intermediate-Risk Oropharyngeal Cancer","volume":"145","author":"Hutcheson","year":"2019","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"B46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejca.2016.09.006","article-title":"Treatment De-intensification Strategies for Head and Neck Cancer","volume":"68","author":"Kelly","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1158\/0008-5472.CAN-13-0587","article-title":"Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer","volume":"73","author":"Kimple","year":"2013","journal-title":"Cancer Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13014-017-0939-0","article-title":"Overcoming Hypoxia-Induced Tumor Radioresistance in Non-small Cell Lung Cancer by Targeting DNA-dependent Protein Kinase in Combination with Carbon Ion Irradiation","volume":"12","author":"Klein","year":"2017","journal-title":"Radiat. Oncol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/J.IJROBP.2009.02.015","article-title":"The Relationship between Human Papillomavirus Status and Other Molecular Prognostic Markers in Head and Neck Squamous Cell Carcinomas","volume":"74","author":"Kong","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B50","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.1158\/1078-0432.CCR-19-1490","article-title":"Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis Among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients","volume":"25","author":"Laban","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/J.RADONC.2008.12.017","article-title":"A Predictive Model for Swallowing Dysfunction after Curative Radiotherapy in Head and Neck Cancer","volume":"90","author":"Langendijk","year":"2009","journal-title":"Radiother. Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/J.RADONC.2009.10.008","article-title":"HPV-associated P16-Expression and Response to Hypoxic Modification of Radiotherapy in Head and Neck Cancer","volume":"94","author":"Lassen","year":"2010","journal-title":"Radiother. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.radonc.2013.08.036","article-title":"Expression of EGFR and HPV-Associated P16 in Oropharyngeal Carcinoma: Correlation and Influence on Prognosis after Radiotherapy in the Randomized DAHANCA 5 and 7 Trials","volume":"108","author":"Lassen","year":"2013","journal-title":"Radiother. Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijrobp.2016.04.027","article-title":"Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent with Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma","volume":"96","author":"Lee","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B55","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","article-title":"Avelumab Plus Standard-Of-Care Chemoradiotherapy versus Chemoradiotherapy Alone in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck: a Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase 3 Trial","volume":"22","author":"Lee","year":"2021","journal-title":"Lancet Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.radonc.2007.07.009","article-title":"Dysphagia Disorders in Patients with Cancer of the Oropharynx Are Significantly Affected by the Radiation Therapy Dose to the superior and Middle Constrictor Muscle: A Dose-Effect Relationship","volume":"85","author":"Levendag","year":"2007","journal-title":"Radiother. Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","article-title":"Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline from the College of American Pathologists","volume":"142","author":"Lewis","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1200\/EDBK_199697","article-title":"Major Changes in Head and Neck Staging for 2018","volume":"38","author":"Lydiatt","year":"2018","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.19.00463","article-title":"Phase II Evaluation of Aggressive Dose De-escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma","volume":"37","author":"Ma","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","article-title":"Factors Associated with Severe Late Toxicity after Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: an RTOG Analysis","volume":"26","author":"Machtay","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1200\/JCO.2016.68.3300","article-title":"E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients with HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group","volume":"35","author":"Marur","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/j.ejca.2014.07.001","article-title":"De-escalation Treatment Protocols for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: a Systematic Review and Meta-Analysis of Current Clinical Trials","volume":"50","author":"Masterson","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/hed.22015","article-title":"Prevalence of Human Papillomavirus in Oropharyngeal and Nonoropharyngeal Head and Neck Cancer-Ssystematic Review and Meta-Analysis of Trends by Time and Region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"key":"B64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy Plus Cisplatin or Cetuximab in Low-Risk Human Papillomavirus-Positive Oropharyngeal Cancer (De-ESCALaTE HPV): an Open-Label Randomised Controlled Phase 3 Trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ctro.2017.10.005","article-title":"Treatment De-escalation for HPV-Driven Oropharyngeal Cancer: Where Do We Stand","volume":"8","author":"Mirghani","year":"2018","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/ijc.28847","article-title":"Treatment De-escalation in HPV-Positive Oropharyngeal Carcinoma: Ongoing Trials, Critical Issues and Perspectives","volume":"136","author":"Mirghani","year":"","journal-title":"Int. J. Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/modpathol.2015.113","article-title":"Diagnosis of HPV-Driven Head and Neck Cancer with a Single Test in Routine Clinical Practice","volume":"28","author":"Mirghani","year":"","journal-title":"Mod. Pathol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/J.ORALONCOLOGY.2019.06.021","article-title":"Standard of Care vs Reduced-Dose Chemoradiation after Induction Chemotherapy in HPV+ Oropharyngeal Carcinoma Patients: The Quarterback Trial","volume":"95","author":"Misiukiewicz","year":"2019","journal-title":"Oral Oncol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/J.RADONC.2012.09.015","article-title":"FAZA PET\/CT Hypoxia Imaging in Patients with Squamous Cell Carcinoma of the Head and Neck Treated with Radiotherapy: Results from the DAHANCA 24 Trial","volume":"105","author":"Mortensen","year":"2012","journal-title":"Radiother. Oncol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","article-title":"Mechanisms of Human Papillomavirus-Induced Oncogenesis","volume":"78","author":"M\u00fcnger","year":"2004","journal-title":"J. Virol."},{"key":"B71","unstructured":"Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-Related, P16 + Oropharynx Cancer\u2014ClinicalTrials. Gov2012"},{"key":"B72","unstructured":"Transoral Surgery Followed by Low-Dose or Standard-Dose Radiation Therapy with or without Chemotherapy in Treating Patients with HPV Positive Stage III-IVA Oropharyngeal Cancer2013"},{"key":"B73","unstructured":"Safety Testing of Adding Nivolumab to Chemotherapy in Patients with Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer - Full Text View - ClinicalTrials.Gov2016"},{"key":"B74","unstructured":"Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer - Full Text View - ClinicalTrials.Gov2016"},{"key":"B75","unstructured":"De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-Positive Head-Neck Squamous Cell Carcinomas2018"},{"key":"B76","unstructured":"Adjuvant De-escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer - ClinicalTrials.Gov2018"},{"key":"B77","unstructured":"Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients with HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma - ClinicalTrials.Gov2019"},{"key":"B78","unstructured":"De-intensified Radiation Therapy with Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients with Early-Stage, HPV-Positive, Non-smoking Associated Oropharyngeal Cancer - ClinicalTrials.Gov2019"},{"key":"B79","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/jamaoncol.2016.4500","article-title":"Immune Response to HPV16 E6 and E7 Proteins and Patient Outcomes in Head and Neck Cancer","volume":"3","author":"Nelson","year":"2017","journal-title":"JAMA Oncol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/J.ORALONCOLOGY.2005.09.003","article-title":"Evolution of Chronic Dysphagia Following Treatment for Head and Neck Cancer","volume":"42","author":"Nguyen","year":"2006","journal-title":"Oral Oncol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/cncr.10257","article-title":"Combined Chemotherapy and Radiation Therapy for Head and Neck Malignancies: Quality of Life Issues","volume":"94","author":"Nguyen","year":"2002","journal-title":"Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12885-020-6607-z","article-title":"Treatment De-escalation for HPV-Associated Oropharyngeal Squamous Cell Carcinoma with Radiotherapy vs. Trans-oral Surgery (ORATOR2): Study Protocol for a Randomized Phase II Trial","volume":"20","author":"Nichols","year":"2020","journal-title":"BMC Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/S1470-2045(19)30410-3","article-title":"Radiotherapy versus Transoral Robotic Surgery and Neck Dissection for Oropharyngeal Squamous Cell Carcinoma (ORATOR): an Open-Label, Phase 2, Randomised Trial","volume":"20","author":"Nichols","year":"2019","journal-title":"Lancet Oncol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and Validation of a Staging System for HPV-Related Oropharyngeal Cancer by the International Collaboration on Oropharyngeal Cancer Network for Staging (ICON-S): a Multicentre Cohort Study","volume":"17","author":"O'Sullivan","year":"2016","journal-title":"Lancet Oncol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s12885-015-1598-x","article-title":"PATHOS: a Phase II\/III Trial of Risk-Stratified, Reduced Intensity Adjuvant Treatment in Patients Undergoing Transoral Surgery for Human Papillomavirus (HPV) Positive Oropharyngeal Cancer","volume":"15","author":"Owadally","year":"2015","journal-title":"BMC Cancer"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/J.IJROBP.2021.09.013","article-title":"A Randomized Trial of Radiotherapy vs. Trans-oral Surgery for Treatment De-escalation in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (ORATOR2)","volume":"111","author":"Palma","year":"2021","journal-title":"Int. J. Radiat. Oncology*Biology*Physics"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1002\/cncr.10567","article-title":"Squamous Cell Carcinoma of the Oropharynx: Surgery, Radiation Therapy, or Both","volume":"94","author":"Parsons","year":"2002","journal-title":"Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/cncr.29921","article-title":"Rising Population of Survivors of Oral Squamous Cell Cancer in the United States","volume":"122","author":"Patel","year":"2016","journal-title":"Cancer"},{"key":"B89","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of Chemotherapy in Head and Neck Cancer (MACH-NC): An Update on 93 Randomised Trials and 17,346 Patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother. Oncol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/ijc.30516","article-title":"Diagnostic Accuracy of p16INK4a Immunohistochemistry in Oropharyngeal Squamous Cell Carcinomas: A Systematic Review and Meta-Analysis","volume":"140","author":"Prigge","year":"2017","journal-title":"Int. J. Cancer"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1093\/annonc\/mdu265","article-title":"The Current and Future Impact of Human Papillomavirus on Treatment of Squamous Cell Carcinoma of the Head and Neck","volume":"25","author":"Psyrri","year":"2014","journal-title":"Ann. Oncol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/154405910708600202","article-title":"The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus","volume":"86","author":"Ragin","year":"2007","journal-title":"J. Dent. Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/ijc.22851","article-title":"Survival of Squamous Cell Carcinoma of the Head and Neck in Relation to Human Papillomavirus Infection: Review and Meta-Analysis","volume":"121","author":"Ragin","year":"2007","journal-title":"Int. J. Cancer"},{"key":"B94","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/J.ORALONCOLOGY.2011.05.012","article-title":"The Impact of Late Treatment-Toxicity on Generic Health-Related Quality of Life in Head and Neck Cancer Patients after Radiotherapy","volume":"47","author":"Ramaekers","year":"2011","journal-title":"Oral Oncol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/ijc.27316","article-title":"Cellular Senescence and Tumor Suppressor Gene P16","volume":"130","author":"Rayess","year":"2012","journal-title":"Int. J. Cancer"},{"key":"B96","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/J.RADONC.2013.03.013","article-title":"HNSCC Cell Lines Positive for HPV and P16 Possess Higher Cellular Radiosensitivity Due to an Impaired DSB Repair Capacity","volume":"107","author":"Rieckmann","year":"2013","journal-title":"Radiother. Oncol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1093\/annonc\/mdt319","article-title":"Human Papillomavirus Detection and Comorbidity: Critical Issues in Selection of Patients with Oropharyngeal Cancer for Treatment De-escalation Trials","volume":"24","author":"Rietbergen","year":"2013","journal-title":"Ann. Oncol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1002\/ijc.28580","article-title":"Molecular Characterization of P16-Immunopositive but HPV DNA-Negative Oropharyngeal Carcinomas","volume":"134","author":"Rietbergen","year":"2014","journal-title":"Int. J. Cancer"},{"key":"B99","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/J.IJROBP.2021.04.015","article-title":"Randomized Trial of Radiation Therapy with Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-tasman Radiation Oncology Group Study","volume":"111","author":"Rischin","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B100","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1200\/JCO.2010.29.2904","article-title":"Prognostic Significance of p16INK4A and Human Papillomavirus in Patients with Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial","volume":"28","author":"Rischin","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1200\/JCO.2015.62.5970","article-title":"Association of Human Papillomavirus and P16 Status with Outcomes in the IMCL-9815 Phase III Registration Trial for Patients with Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated with Radiotherapy with or without Cetuximab","volume":"34","author":"Rosenthal","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1002\/cncr.28672","article-title":"Patterns of Symptom burden during Radiotherapy or Concurrent Chemoradiotherapy for Head and Neck Cancer: A Prospective Analysis Using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module","volume":"120","author":"Rosenthal","year":"2014","journal-title":"Cancer"},{"key":"B103","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/hed.26022","article-title":"Pathologic Response to Neoadjuvant Chemotherapy in HPV\u2010associated Oropharynx Cancer","volume":"42","author":"Sadeghi","year":"2019","journal-title":"Head Neck"},{"key":"B104","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1158\/1078-0432.CCR-11-0388","article-title":"Evaluation of Human Papilloma Virus Diagnostic Testing in Oropharyngeal Squamous Cell Carcinoma: Sensitivity, Specificity, and Prognostic Discrimination","volume":"17","author":"Schache","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/annonc\/mdy522","article-title":"OPTIMA: a Phase II Dose and Volume De-escalation Trial for Human Papillomavirus-Positive Oropharyngeal Cancer","volume":"30","author":"Seiwert","year":"2019","journal-title":"Ann. Oncol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"724","DOI":"10.15585\/MMWR.MM6833A3","article-title":"Human Papillomavirus-Attributable Cancers - United States, 2012-2016","volume":"68","author":"Senkomago","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/lary.26796","article-title":"Quality of Life Outcomes of Transoral Robotic Surgery with or without Adjuvant Therapy for Oropharyngeal Cancer","volume":"128","author":"Sethia","year":"2018","journal-title":"Laryngoscope"},{"key":"B108","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1200\/JCO.2009.23.1670","article-title":"Comparative Prognostic Value of HPV16 E6 mRNA Compared with In Situ Hybridization for Human Oropharyngeal Squamous Carcinoma","volume":"27","author":"Shi","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/PAS.0000000000001685","article-title":"Oropharyngeal Squamous Cell Carcinoma with Discordant P16 and HPV mRNA Results: Incidence and Characterization in a Large, Contemporary United States Cohort","volume":"45","author":"Shinn","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1002\/cncr.25033","article-title":"Comparison of Human Papillomavirus In Situ Hybridization and P16 Immunohistochemistry in the Detection of Human Papillomavirus-Associated Head and Neck Cancer Based on a Prospective Clinical Experience","volume":"116","author":"Singhi","year":"2010","journal-title":"Cancer"},{"key":"B111","doi-asserted-by":"publisher","first-page":"viii399","DOI":"10.1093\/annonc\/mdy287.080","article-title":"A Randomized Phase II Study of Cisplatin Plus Radiotherapy versus Durvalumab Plus Radiotherapy Followed by Adjuvant Durvalumab versus Durvalumab Plus Radiotherapy Followed by Adjuvant Tremelimumab and Durvalumab in Intermediate Risk, HPV-Positive, Locoregionally Advanced Oropharyngeal Squamous Cell Cancer (LA-OSCC) (Canadian Cancer Trials Group HN.9)","volume":"29","author":"Spreafico","year":"2018","journal-title":"Ann. Oncol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/lary.28580","article-title":"Bleeding Complications after Transoral Robotic Surgery: A Meta-Analysis and Systematic Review","volume":"131","author":"Stokes","year":"2021","journal-title":"Laryngoscope"},{"key":"B113","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/IJC.33798","article-title":"Performance of Oral HPV DNA, Oral HPV mRNA and Circulating Tumor HPV DNA in the Detection of HPV-Related Oropharyngeal Cancer and Cancer of Unknown Primary","volume":"150","author":"Tanaka","year":"2022","journal-title":"Int. J. Cancer"},{"key":"B114","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/J.RADONC.2011.09.010","article-title":"Gene Expression Classifier Predicts for Hypoxic Modification of Radiotherapy with Nimorazole in Squamous Cell Carcinomas of the Head and Neck","volume":"102","author":"Toustrup","year":"2012","journal-title":"Radiother. Oncol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0360-3016(99)00558-1","article-title":"Toxicity in Head and Neck Cancer: a Review of Trends and Issues","volume":"47","author":"Trotti","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B116","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1007\/s12105-012-0372-5","article-title":"HPV Detection Methods in Head and Neck Cancer","author":"Venuti","year":"2012","journal-title":"Head Neck Pathol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1200\/EDBK_238315","article-title":"Point\/Counterpoint: Do We De-escalate Treatment of HPV-Associated Oropharynx Cancer Now? and How","volume":"39","author":"Wirth","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"B118","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/J.ORALONCOLOGY.2017.08.020","article-title":"Appraisal of the AJCC 8th Edition Pathologic Staging Modifications for HPV-Positive Oropharyngeal Cancer, a Study of the National Cancer Data Base","volume":"73","author":"Zhan","year":"2017","journal-title":"Oral Oncol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.753387\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T05:48:41Z","timestamp":1642657721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.753387\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":119,"alternative-id":["10.3389\/fphar.2021.753387"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.753387","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"article-number":"753387"}}